Ashwin Balagopal, MD

• Chair, ACTG 5335s
• Investigator ACTG 5329 and ACTG 5334s
• Investigator, Hepatitis Transformative Science Group (Feb 2016)

This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...

Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...

The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...

TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...

1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

Johns Hopkins University Baltimore-India Clinical Trials Unit